Ravindra Kumar, VP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 5,500 shares at $42.04 ($225K) on 2015-03-04, disclosed to the SEC on 2015-03-06.
Scheduled sale ($225k) by VP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.56 | 2,086 | $85K | 37.6% |
| 2 | $40.62 | 1,034 | $42K | 18.7% |
| 3 | $41.09 | 366 | $15K | 6.7% |
| 4 | $41.22 | 1,614 | $67K | 29.6% |
| 5 | $42.04 | 100 | $4K | 1.9% |
| 6 | $42.06 | 300 |
| $13K |
| 5.6% |
| Total | $40.91 avg | 5,500 | $225K | 100% |
| Filing → |
| XLRN | SELL | 2019-01-04 | $249K | — | Filing → |
| XLRN | SELL | 2018-04-04 | $46K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |